Topic: Zyprexa

Eli Lilly and Co. faced scrutiny for urging doctors to prescribe the antipsychotic drug Zyprexa to elderly patients with dementia, despite evidence that the drug was ineffective and increased the risk of death. Zyprexa, which generates billions in annual sales, is officially approved for schizophrenia and bipolar disorder. The hosts criticize the pharmaceutical industry for "off-label" promotion and the widespread use of mood-stabilizing drugs like lithium and Ritalin.